PCVX
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Vaxcyte, Inc. - Common Stock (PCVX) [ST]
www.vaxcyte.com ↗▲ 4.89%
prev close
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Congressional Trades
6
All tracked trades
Members Trading
3
Unique members
Net Activity
+4
5 buys · 1 sells
Members Who Traded This Stock
6 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-07-16 | PCVXVaxcyte, Inc. - Common Stock | Buy | $1,001 - $15,000 | 46d ago | — | |
| 2026-05-13 | PCVXVaxcyte, Inc. - Common Stock | Buy | $1,001 - $15,000 | 134d ago | — | |
| 2026-05-12 | PCVXVaxcyte, Inc. - Common Stock | Buy | $1,001 - $15,000 | 134d ago | — | |
| 2025-04-15 | PCVXVaxcyte, Inc. - Common Stock | Buy | $1,001 - $15,000 | 532d ago | — | |
| 2025-03-05 | PCVXVaxcyte, Inc. - Common Stock | Sell | $15,001 - $50,000 | 557d ago | — | |
| 2022-11-08 | PCVXVaxcyte, Inc. - Common Stock | Buy | $1,001 - $15,000 | 1408d ago | — |
2026-07-16
Gilbert Cisneros
PCVX
Amount
$1,001 - $15,000
Filed
46d ago
2026-05-13
Gilbert Cisneros
PCVX
Amount
$1,001 - $15,000
Filed
134d ago
2026-05-12
Gilbert Cisneros
PCVX
Amount
$1,001 - $15,000
Filed
134d ago
2025-04-15
Gilbert Cisneros
PCVX
Amount
$1,001 - $15,000
Filed
532d ago
2025-03-05
Jefferson Shreve
PCVX
Amount
$15,001 - $50,000
Filed
557d ago
2022-11-08
Christopher L. Jacobs
PCVX
Amount
$1,001 - $15,000
Filed
1408d ago
Recent News
Powered by Polygon.io
Wall Street Analysts Think Vaxcyte (PCVX) Could Surge 75.6%: Read This Before Placing a Bet
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?
Stock Market Today, Oct. 5: Tech Momentum Lifts Nasdaq as Treasury Yields Surge
The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte
Trade Timeline
Congressional activity, newest first
Gilbert Cisneros
2026-07-16 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2026-05-13 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2026-05-12 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2025-04-15 · Purchase
$1,001 - $15,000
Jefferson Shreve
2025-03-05 · Sale
$15,001 - $50,000
Christopher L. Jacobs
2022-11-08 · Purchase
$1,001 - $15,000